Osteoma secondary prevention: Difference between revisions
Mahshid |
|||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Osteoma}} | |||
{{CMG}}{{AE}}{{MV}} | |||
==Overview== | |||
Secondary prevention for osteoma includes screening for multiple osteomas among patients with family history or/and a confirmed diagnosis of Gardner syndrome. Thyroid exam and annual ultrasound, should be performed starting at age 10 to 12 years.<ref name="pmid24093640">{{cite journal |vauthors=Septer S, Slowik V, Morgan R, Dai H, Attard T |title=Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals |journal=Hered Cancer Clin Pract |volume=11 |issue=1 |pages=13 |year=2013 |pmid=24093640 |pmc=3854022 |doi=10.1186/1897-4287-11-13 |url=}}</ref> | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Line 6: | Line 10: | ||
==References== | ==References== | ||
{{reflist|1}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Orthopedics]] |
Latest revision as of 14:54, 27 November 2017
Osteoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Osteoma secondary prevention On the Web |
American Roentgen Ray Society Images of Osteoma secondary prevention |
Risk calculators and risk factors for Osteoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Secondary prevention for osteoma includes screening for multiple osteomas among patients with family history or/and a confirmed diagnosis of Gardner syndrome. Thyroid exam and annual ultrasound, should be performed starting at age 10 to 12 years.[1]
Secondary Prevention
Secondary prevention for osteoma includes screening for multiple osteomas among patients with family history or/and a confirmed diagnosis of Gardner syndrome. Thyroid exam and annual ultrasound, should be performed starting at age 10 to 12 years.[1]
References
- ↑ 1.0 1.1 Septer S, Slowik V, Morgan R, Dai H, Attard T (2013). "Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals". Hered Cancer Clin Pract. 11 (1): 13. doi:10.1186/1897-4287-11-13. PMC 3854022. PMID 24093640.